Clearside Biomedical
在场
Clearside Biomedical 是一家在股票代码 CLSD (US) 下上市的公司。
涉及Clearside Biomedical的并购和融资。
- Clearside Biomedical 刚刚宣布为 65 筹款数百万美元。 (公布2022八月11号).
高管
查看带有其 18 名主要高管的组织结构图
Clearside Biomedical 搜索最多的简介
- George Lasezkay, Chief Executive Officer and Director
- Christy Shaffer, Director
- William Humphries, Director
高管在Clearside Biomedical变化
- Anthony Gibney已作为Director加入公司 (新闻发布的2024四月17号).
- Victor Chong已作为Chief Medical Officer加入公司 (新闻发布的2024三月19号).
创建提醒
跟踪 Clearside Biomedical 的高管变动
生物技术
Clearside Biomedical 拥有 2,290 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Delphia Therapeutics 刚刚宣布为 67 筹款数百万美元。 (公布2024五月7号).
- Karius 刚刚宣布为 100 筹款数百万美元。 (公布2024五月3号).
- Transcarent 刚刚宣布为 126 筹款数百万美元。 (公布2024五月2号).
生物技术 行业的其他推荐联系人
消息
Clearside Biomedical 的最新新闻稿
- Clearside Biomedical Announces Clinical Data Presentations at The Retina Society 2020 and Publication of XIPERE™ Data in Diabetic Macular Edema in Ophthalmology Retina | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical’s Oncology Licensing Partner Doses First Patient in its Phase 2 Study in Patients with Choroidal Melanoma Using SCS Microinjector® for Suprachoroidal Delivery | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical to Present at the Virtual H.C. Wainwright 22nd Annual Global Investment Conference | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical’s Licensing Partner Doses First Patient in its Phase 2 Gene Therapy Trial Using SCS Microinjector® for Suprachoroidal Delivery | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Expands Patent Portfolio in the U.S. and Europe | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces Second Quarter 2020 Financial Results and Provides Corporate Update | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces U.S. FDA Acceptance of Investigational New Drug Application for CLS-AX (axitinib injectable suspension) Administered in Suprachoroidal Space | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical to Report Second Quarter 2020 Financial Results and Provide Corporate Update on Monday, August 10, 2020 | Clearside Biomedical, Inc.- IR Site
- Clearside Biomedical Announces Multiple Presentations at the ASRS 2020 Virtual Annual Meeting | Clearside Biomedical, Inc.- IR Site
- View more press releases Close
通过电子邮件
